- Home
- BDC vs TERN Comparison
BDC vs TERN Comparison
Compare BDC & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDC | TERN |
|---|---|---|
| Founded | 1902 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 4.5B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BDC | TERN |
|---|---|---|
| Price | $142.69 | $41.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $148.33 | $48.60 |
| AVG Volume (30 Days) | 323.3K | ★ 1.7M |
| Earning Date | 05-13-2026 | 04-17-2026 |
| Dividend Yield | ★ 0.14% | N/A |
| EPS Growth | ★ 23.13 | 11.81 |
| EPS | ★ 5.91 | N/A |
| Revenue | ★ $2,715,194,000.00 | N/A |
| Revenue This Year | $8.80 | N/A |
| Revenue Next Year | $4.67 | N/A |
| P/E Ratio | $24.24 | ★ N/A |
| Revenue Growth | ★ 10.33 | N/A |
| 52 Week Low | $83.18 | $1.87 |
| 52 Week High | $159.99 | $48.26 |
Technical Indicators
Market Signals| Indicator | BDC | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 58.64 | 66.21 |
| Support Level | $107.97 | $39.15 |
| Resistance Level | $159.99 | $48.26 |
| Average True Range (ATR) | 5.03 | 2.02 |
| MACD | -0.83 | 0.32 |
| Stochastic Oscillator | 15.22 | 85.32 |
Price Performance
Historical ComparisonAbout BDC Belden Inc
Belden Inc is a supplier of complete connection solutions. It has two segments, Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions provides network infrastructure and broadband solutions, serving markets such as data centers, government, healthcare, and broadband and wireless service providers, with products including copper and fiber cable and connectivity solutions. Automation Solutions provides digitization and automation solutions that enable IT OT convergence and support acquisition, transmission, orchestration, and management, serving markets including Warehousing and Logistics, Energy, Transportation, and Discrete Manufacturing. The company operates in the Americas, EMEA, and APAC, with maximum revenue coming from the Americas.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.